Improving document co-authoring and review practices in highly regulated industries

What if your next document review took days instead of weeks? Organizations in pharma, biotech, government and defense are cutting review time by 65% and costs by 35% with a complete audit trail built in. 

CLOSE

COLOUR-IMAGE_people-working-in-office_feb26
overview

Streamline document co-authoring and review through automation

In industries where a single submission can involve hundreds of documents and dozens of reviewers, the stakes of a slow or disorganized review process are high. This guide breaks down how organizations across pharma, biotech, clinical research, government and defense have modernized their approach — and what you can learn from their results.

Key takeaways

Why you need this guide

Discover the strategies and benefits of automating document co-authoring and review processes. 

Version control at scale

See how organizations eliminate conflicting document versions and give every reviewer a single source of truth, even with 200+ simultaneous participants. 

Audit-ready by design

Understand how a complete, immutable audit trail replaces hours of manual activity reconstruction before regulatory inspections.

Secure external collaboration

Learn how teams safely involve CROs, consultants and external stakeholders without granting access to internal systems.

Real-world results

Industry-specific case studies from pharmaceutical, government and defense organizations, including how one team cut a 24-day review cycle to 8 days.

Why SharePoint isn't enough

Understand exactly where generic tools run out of road and what purpose-built review software does differently.

Trusted by 85% of the top 25 global pharma companies and 4 out of the top 5 CROs

See how leading organizations in pharma, biotech, government and defense are cutting review time, reducing costs and staying audit-ready.